SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is surging as retail investors pivot to the space sector, fueled by intense momentum, a highly shorted float, and persistent confusion over the ticker's similarity to upcoming high-profile space IPOs. Community sentiment is deeply polarized, with bulls betting on a textbook short squeeze and long-term sector growth, while skeptics view the price action as a classic speculative pump-and-dump disconnected from fundamentals.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin ($BNKR.X) is gaining traction as community members highlight its role as essential infrastructure for autonomous on-chain AI agents within the Base ecosystem. Investors are actively discussing the token's accumulation phase, potential for long-term utility-driven growth, and the ongoing development of its bot capabilities that facilitate on-chain DeFi transactions.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as the Bitwise XRP ETF attracts significant institutional inflows while outperforming Bitcoin and Ether funds, sparking community debate over the asset's long-term utility in global payment systems. The community is actively discussing the potential impact of legislative developments like the Clarity Act and the tokenization of real-world assets on future institutional adoption.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is seeing significant market enthusiasm following a major federal initiative designating the company as a key partner in establishing the first U.S.-based quantum chip foundry. Community discussions are heavily centered on this strategic government backing, with many investors highlighting the stock's pivot toward quantum computing and AI infrastructure as a long-term growth catalyst.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing significant upward momentum as investors position themselves for potential catalysts in the AI and Co-Packaged Optics sectors, driven by anticipation surrounding its supply chain integration with Nvidia and TSMC. The community is actively debating the company's long-term pivot toward Edge AI and optical hardware, closely monitoring upcoming earnings and guidance for confirmation of its strategic growth.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing significant community discussion as investors brace for upcoming maintenance trial data, which is viewed as a crucial catalyst for confirming the drug's long-term efficacy and tolerability against major competitors. While the stock continues to be influenced by short-term volatility and sector-wide dynamics, bulls remain focused on the potential for a transformative buyout or partnership, fueled by the company's dual-formulation pipeline and its positioning against larger industry incumbents.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending as retail investors and institutions like ARK Invest capitalize on government-backed funding rumors and defense sector rotation. The community is heavily focused on the company's role in autonomous drone manufacturing and hypersonic tech, with many bullishly eyeing the upcoming earnings report as a potential catalyst for a sustained breakout.

SPDR Series Trust - State Street SPDR S&P Metals & Mining ETF

SPDR Metals & Mining ETF

SPDR Metals & Mining ETF (XME) is trending following a series of successful "Blue Box" technical setups that confirmed a bullish Elliott Wave structure and a confirmed higher-high sequence. Investors are actively discussing the strength of this rally and debating potential upside targets as the sector demonstrates relative strength compared to broader market indices.

iShares Trust - iShares MSCI India ETF

iShares MSCI India ETF

The iShares MSCI India ETF (INDA) is currently in focus as investors weigh the potential for a landmark U.S.-India trade deal against ongoing geopolitical risks and tariff tensions. Community discourse remains divided, with many monitoring the impact of shifting supply chains and central bank policy on long-term growth prospects.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors due to its upcoming earnings report and the broader anticipation surrounding the 'immune reset' mechanism of its lead asset, soquelitinib. Community discourse is heavily divided between vocal bulls expecting a major buyout or partnership catalyst following recent institutional interest and price target upgrades, and skeptical bears who are focusing on the company's early-stage pipeline and high cash burn rate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In...

Plurilock Gets $1.2 Mln Software And Services Contract

(RTTNews) - Plurilock Security Inc. (PLUR.V, PLCKF), a cybersecurity systems integrator, on Tuesday announced that it has been awarded a new contract totalling $1.2 million for software licensing and...

Alexandre Weinstein Manieu Purchases 452,702 Shares of Pluri (NASDAQ:PLUR) Stock

Pluri Inc. (NASDAQ:PLUR - Get Free Report) Director Alexandre Weinstein Manieu purchased 452,702 shares of the company's stock in a transaction that occurred on Monday, April 28th. The shares were...

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

PLUR
Pluri Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest PLUR News

PLURPluri Inc